Against this background, we were interested in the functional state of melanopsin-expressing retinal ganglion cells (mRGCs) as a potential biomarker for sleep–wake abnormalities and CNS involvement in CIDP. This evidence concerns the gene OPN4 and chronic inflammatory demyelinating polyradiculoneuropathy.